Tzvetkov MV - Search Results

1

Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. Gong L, et al. Among authors: tzvetkov mv. Pharmacogenet Genomics. 2014 Jul;24(7):374-80. doi: 10.1097/FPC.0000000000000057. Pharmacogenet Genomics. 2014. PMID: 24849324 Free PMC article. No abstract available.

2

Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.

Stamer UM, Musshoff F, Stüber F, Brockmöller J, Steffens M, Tzvetkov MV. Stamer UM, et al. Among authors: tzvetkov mv. Pain. 2016 Nov;157(11):2467-2475. doi: 10.1097/j.pain.0000000000000662. Pain. 2016. PMID: 27541716

3

Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.

Tzvetkov MV, Brockmöller J, Roots I, Kirchheiner J. Tzvetkov MV, et al. Pharmacogenet Genomics. 2008 Jun;18(6):495-506. doi: 10.1097/FPC.0b013e3282fb02cb. Pharmacogenet Genomics. 2008. PMID: 18496129 Clinical Trial.

4

Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene.

Meineke C, Tzvetkov MV, Bokelmann K, Oetjen E, Hirsch-Ernst K, Kaiser R, Brockmöller J. Meineke C, et al. Among authors: tzvetkov mv. Pharmacogenet Genomics. 2008 Mar;18(3):219-30. doi: 10.1097/FPC.0b013e3282f51092. Pharmacogenet Genomics. 2008. PMID: 18300944

5

Bioinformatic and functional analysis of TGFBR1 polymorphisms.

Schirmer MA, Hoffmann AO, Campean R, Janke JH, Zidek LM, Hoffmann M, Kruse M, Sehrt D, Tzvetkov MV, Rave-Fränk M, Brockmöller J. Schirmer MA, et al. Among authors: tzvetkov mv. Pharmacogenet Genomics. 2009 Apr;19(4):249-59. doi: 10.1097/FPC.0b013e32831cb5a7. Pharmacogenet Genomics. 2009. PMID: 19214138

6

Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets.

Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, Roots I, Brockmöller J. Kirchheiner J, et al. Pharmacogenet Genomics. 2005 Aug;15(8):579-87. doi: 10.1097/01.fpc.0000167331.30905.9e. Pharmacogenet Genomics. 2005. PMID: 16007002

7

Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.

Tzvetkov MV, Saadatmand AR, Lötsch J, Tegeder I, Stingl JC, Brockmöller J. Tzvetkov MV, et al. Clin Pharmacol Ther. 2011 Jul;90(1):143-50. doi: 10.1038/clpt.2011.56. Epub 2011 May 11. Clin Pharmacol Ther. 2011. PMID: 21562485

8

OCT1 pharmacogenetics in pain management: is a clinical application within reach?

Tzvetkov MV. Tzvetkov MV. Pharmacogenomics. 2017 Nov;18(16):1515-1523. doi: 10.2217/pgs-2017-0095. Epub 2017 Oct 24. Pharmacogenomics. 2017. PMID: 29061087 Review.

9

Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.

Tzvetkov M, von Ahsen N. Tzvetkov M, et al. Pathology. 2012 Feb;44(2):166-80. doi: 10.1097/PAT.0b013e32834f4d69. Pathology. 2012. PMID: 22228255 Review.

10

Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.

Sachse-Seeboth C, Pfeil J, Sehrt D, Meineke I, Tzvetkov M, Bruns E, Poser W, Vormfelde SV, Brockmöller J. Sachse-Seeboth C, et al. Clin Pharmacol Ther. 2009 Mar;85(3):273-6. doi: 10.1038/clpt.2008.213. Epub 2008 Nov 12. Clin Pharmacol Ther. 2009. PMID: 19005461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page